Advertisement
UK markets closed
  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     
  • FTSE 250

    20,786.65
    +176.31 (+0.86%)
     
  • AIM

    774.39
    +4.97 (+0.65%)
     
  • GBP/EUR

    1.1819
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2813
    +0.0052 (+0.41%)
     
  • Bitcoin GBP

    44,935.67
    +756.40 (+1.71%)
     
  • CMC Crypto 200

    1,192.21
    -16.48 (-1.36%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • DOW

    39,375.87
    +67.87 (+0.17%)
     
  • CRUDE OIL

    83.44
    -0.44 (-0.52%)
     
  • GOLD FUTURES

    2,399.80
    +30.40 (+1.28%)
     
  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     
  • HANG SENG

    17,799.61
    -228.67 (-1.27%)
     
  • DAX

    18,475.45
    +24.97 (+0.14%)
     
  • CAC 40

    7,675.62
    -20.16 (-0.26%)
     

Zacks Investment Ideas feature highlights: Cigna

For Immediate Release

Chicago, IL – October 17, 2022 – Today, Zacks Investment Ideas feature highlights Cigna Corp. CI.

Insurance Giant Showing Immunity to This Year's Market Volatility

As stocks continue to hover near the lows of the year, the question of whether we’ve hit a bottom for this bear market remains. A lot of damage has occurred, particularly in growth and technology stocks, as the Nasdaq has fallen over 33% from its November 2021 peak. Much has been discounted in the stock market in terms of the slowing growth that lies ahead.

Will we encounter heavy selling on outsized volume, marking a capitulation meltdown as we’ve seen at previous troughs, or will it be more of a quiet bottom and slow, gliding trend back upward?

ADVERTISEMENT

The two big question marks are inflation and the Fed. As we’ve seen with September’s inflation readings for both PPI and CPI, higher prices continue to linger despite the Fed’s thwarting attempts. However, certain inflation components appear to have peaked, potentially paving the way for the Fed to take its foot off the gas pedal.

Despite a very difficult year for most stocks, we’ve seen pockets of strength in several different sectors such as energy and insurance. These pockets have illustrated resilience, and rather than succumb to higher inflation, they’ve actually benefited from higher prices. We’re going to focus on the latter, which has held up very well this year.

The Zacks Insurance – Multi Line is ranked in the top 31% out of approximately 250 industry groups. Because it is ranked in the top half of all Zacks Ranked Industries, we expect this group to outperform the market over the next 3 to 6 months.

Let’s take a deeper look at a top-rated stock within this leading industry.

Cigna Corp.

Cigna provides insurance and related products and services in the United States. The company offers pharmacy, benefits management, care delivery, and intelligence solutions to health plans, employers, government organizations, and health care providers. CI distributes its products and services through insurance brokers and consultants, as well as directly to employers and other groups.

CI has exceeded earnings estimates in each of the past four quarters, with an average surprise of 10.74% over that timeframe. The insurance giant most recently reported Q2 EPS back in August of $6.22/share, a 14.34% beat over the $5.44 consensus estimate. Shares have bucked the trend this year, rising nearly 30% and showing relatively little volatility.

What the Zacks Model Reveals

The Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The technique has proven to be very useful for finding positive earnings surprises. In fact, when combining a Zacks #3 rank or better and a positive earnings ESP, stocks produced a positive surprise 70% of the time.

Cigna’s ESP presently sits at +0.07%. As a Zacks Rank #2 (Buy) stock, it appears CI is yet again primed for another positive earnings surprise when the company reports Q3 earnings on November 3rd.

Make sure to put CI on your watchlist if you haven’t already done so.

Disclaimer: The Zacks Income Investor Service currently has a position in Cigna.

Why Haven’t You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared  +40.3%, +48.2%, +67.6%, +94.4%, and  +95.3%. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cigna Corporation (CI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research